Evidence map›Paper›PMID 41000584›Full record

ArticleO&G open2024

An Argument for Decentralized Clinical Trials in Gynecologic Oncology.

Shilpa Mokshagundam, Michaela E McGree, Angela J Fought, Karen P Ishitani, Carrie L Langstraat, Siddhartha Yadav, Sean C Dowdy, Amanika Kumar

Abstract read
In one paragraph

Article in O&G open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shilpa MokshagundamDepartments of Obstetrics and Gynecology, Quantitative Health Sciences, and Oncology, Mayo Clinic, Rochester, Minnesota.
Michaela E McGreeDepartments of Obstetrics and Gynecology, Quantitative Health Sciences, and Oncology, Mayo Clinic, Rochester, Minnesota.
Angela J FoughtDepartments of Obstetrics and Gynecology, Quantitative Health Sciences, and Oncology, Mayo Clinic, Rochester, Minnesota.
Karen P IshitaniDepartments of Obstetrics and Gynecology, Quantitative Health Sciences, and Oncology, Mayo Clinic, Rochester, Minnesota.
Carrie L LangstraatDepartments of Obstetrics and Gynecology, Quantitative Health Sciences, and Oncology, Mayo Clinic, Rochester, Minnesota.
Siddhartha YadavDepartments of Obstetrics and Gynecology, Quantitative Health Sciences, and Oncology, Mayo Clinic, Rochester, Minnesota.
Sean C DowdyDepartments of Obstetrics and Gynecology, Quantitative Health Sciences, and Oncology, Mayo Clinic, Rochester, Minnesota.
Amanika KumarDepartments of Obstetrics and Gynecology, Quantitative Health Sciences, and Oncology, Mayo Clinic, Rochester, Minnesota.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate factors that may influence clinical trial enrollment, we compared demographics, clinical characteristics, and patient-reported social determinants of health for patients with advanced ovarian cancer who were approached for enrollment in a prehabilitation trial. Although no significant differences were found in the majority of demographic and clinical characteristics, distance to study institution was associated with decision to enroll; 21.9% of enrolled compared with 42.2% of not enrolled patients lived 200 miles or more from the study institution (

Identifiers

PMID41000584
PMCPMC12456598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.